Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Lymphoma 14Sarcoma 13Lymphoma, Large B-Cell, Diffuse 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Leukemia 9Burkitt Lymphoma 7Lymphoma, Mantle-Cell 6Lymphoma, Follicular 6Lung Neoplasms 6Neuroectodermal Tumors, Primitive, Peripheral 5Lymphoma, Non-Hodgkin 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large-Cell, Anaplastic 5Lymphoma, B-Cell, Marginal Zone 5Liposarcoma 5Leukemia, Lymphocytic, Chronic, B-Cell 5Fibrosarcoma 5Neuroblastoma 4Hodgkin Disease 4Hemangiosarcoma 4Carcinoma, Non-Small-Cell Lung 4Testicular Neoplasms 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Ovarian Neoplasms 3Malignant mesenchymal tumor 3Leukemia, Myeloid, Acute 3Hemangiopericytoma, Malignant 3Dendritic Cell Sarcoma, Interdigitating 3Central Nervous System Neoplasms 3Blast Crisis 3

Interventions

sargramostim 1indolepropanol phosphate 1Vincristine 1Tirapazamine 1Pharmacogenomic Testing 1Irinotecan 1Ifosfamide 1Granulocyte-Macrophage Colony-Stimulating Factor 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Alveolar Childhood Rhabdomyosarcoma × Ifosfamide × Clear all
NCT00025363 2013-01-17

Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma

National Cancer Institute (NCI)

Phase 2 Completed
150 enrolled
Sarcoma

Alveolar Childhood Rhabdomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡